These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26827785)

  • 1. Neuroimaging biomarkers in Alzheimer's disease and other dementias.
    Villemagne VL; Chételat G
    Ageing Res Rev; 2016 Sep; 30():4-16. PubMed ID: 26827785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ-amyloid and Tau Imaging in Dementia.
    Villemagne VL; Doré V; Bourgeat P; Burnham SC; Laws S; Salvado O; Masters CL; Rowe CC
    Semin Nucl Med; 2017 Jan; 47(1):75-88. PubMed ID: 27987560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.
    Villemagne VL; Fodero-Tavoletti MT; Pike KE; Cappai R; Masters CL; Rowe CC
    Mol Neurobiol; 2008 Aug; 38(1):1-15. PubMed ID: 18690556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid imaging.
    Villemagne VL; Rowe CC
    Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S41-9. PubMed ID: 21729418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid imaging in Alzheimer's disease and other dementias.
    Fodero-Tavoletti MT; Cappai R; McLean CA; Pike KE; Adlard PA; Cowie T; Connor AR; Masters CL; Rowe CC; Villemagne VL
    Brain Imaging Behav; 2009 Sep; 3(3):246-61. PubMed ID: 22005989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
    Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease.
    Pandya S; Kuceyeski A; Raj A;
    J Alzheimers Dis; 2017; 55(4):1639-1657. PubMed ID: 27911289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation.
    Arenaza-Urquijo EM; Bejanin A; Gonneaud J; Wirth M; La Joie R; Mutlu J; Gaubert M; Landeau B; de la Sayette V; Eustache F; Chételat G
    Neurobiol Aging; 2017 Nov; 59():72-79. PubMed ID: 28764930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid imaging: Past, present and future perspectives.
    Villemagne VL
    Ageing Res Rev; 2016 Sep; 30():95-106. PubMed ID: 26827784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of brain amyloid in dementia: a review.
    Quigley H; Colloby SJ; O'Brien JT
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline.
    Hua J; Lee S; Blair NIS; Wyss M; van Bergen JMG; Schreiner SJ; Kagerer SM; Leh SE; Gietl AF; Treyer V; Buck A; Nitsch RM; Pruessmann KP; Lu H; Van Zijl PCM; Albert M; Hock C; Unschuld PG
    Neurobiol Aging; 2019 Apr; 76():181-193. PubMed ID: 30738323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on biomarkers for amyloid pathology in Alzheimer's disease.
    Ashton NJ; Schöll M; Heurling K; Gkanatsiou E; Portelius E; Höglund K; Brinkmalm G; Hye A; Blennow K; Zetterberg H
    Biomark Med; 2018 Jul; 12(7):799-812. PubMed ID: 29902934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
    Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
    Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.